The FDA has released a Form 483 from the inspection of the Immunomedics plant showing big issues with data integrity at the Morris Plains, New Jersey, plant where sacituzumab govitecan is being made.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,